文献速递认知障碍与痴呆帕金森病与运动障碍

评估阿尔茨海默病相关生物标志物变化对皮质基底节综合征和进行性核上性麻痹的影响

Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.
PubMed 文献 · Ann Neurol · 2024-04-05

研究比较了AD生物标志物阳性与阴性的CBS/PSP患者的临床特征、脑萎缩和功能连接,发现AD阳性患者运动症状较轻,但默认网络连接更差,提示AD病理可调节临床表现。

要点

  • AD阳性CBS/PSP患者PSPRS和UPDRS评分低于AD阴性患者。
  • AD阳性患者显示AD特征区和脑干萎缩,AD阴性患者显示额颞区、苍白球和脑干萎缩。
  • 默认网络连接在AD阳性患者中受损最重,丘脑网络连接在AD阴性患者中受损最重。

主要发现

  • CBS/PSP-noAD组PSPRS评分均值(标准差)为34.8(15.8),CBS/PSP-AD组为23.3(11.6)。
  • CBS/PSP-noAD组UPDRS评分均值(标准差)为34.2(17.0),CBS/PSP-AD组为21.8(13.3)。
  • 与健康对照相比,CBS/PSP-AD组在AD特征区和脑干出现萎缩,CBS/PSP-noAD组在额颞区、苍白球和脑干出现萎缩。
  • 与CBS/PSP-noAD组和健康对照相比,CBS/PSP-AD组默认网络连接断开最严重;CBS/PSP-noAD组丘脑网络连接受影响最重。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the effect of Alzheimer's disease (AD) -related biomarker change on clinical features, brain atrophy and functional connectivity of patients with corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). METHODS: Data from patients with a clinical diagnosis of CBS, PSP, and AD and healthy controls were obtained from the 4-R-Tauopathy Neuroimaging Initiative 1 and 2, the Alzheimer's Disease Neuroimaging Initiative, and a local cohort from the Toronto Western Hospital. Patients with CBS and PSP were divided into AD-positive (CBS/PSP-AD) and AD-negative (CBS/PSP-noAD) groups based on fluid biomarkers and amyloid PET scans. Cognitive, motor, and depression scores; AD fluid biomarkers (cerebrospinal p-tau, t-tau, and amyloid-beta, and plasma ptau-217); and neuroimaging data (amyloid PET, MRI and fMRI) were collected. Clinical features, whole-brain gray matter volume and functional networks connectivity were compared across groups. RESULTS: Data were analyzed from 87 CBS/PSP-noAD and 23 CBS/PSP-AD, 18 AD, and 30 healthy controls. CBS/PSP-noAD showed worse performance in comparison to CBS/PSP-AD in the PSPRS [mean(SD): 34.8(15.8) vs 23.3(11.6)] and the UPDRS scores [mean(SD): 34.2(17.0) vs 21.8(13.3)]. CBS/PSP-AD demonstrated atrophy in AD signature areas and brainstem, while CBS/PSP-noAD patients displayed atrophy in frontal and temporal areas, globus pallidus, and brainstem compared to healthy controls. The default mode network showed greatest disconnection in CBS/PSP-AD compared with CBS/PSP-no AD and controls. The thalamic network connectivity was most affected in CBS/PSP-noAD. INTERPRETATION: AD biomarker positivity may modulate the clinical presentation of CBS/PSP, with evidence of distinctive structural and functional brain changes associated with the AD pathology/co-pathology. ANN NEUROL 2024;96:99-109.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Garcia-Cordero I, Anastassiadis C, Khoja A, et al. Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy. Ann Neurol. 2024. PMID: 38578117. doi:10.1002/ana.26930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。